# Randomized Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal GVHD

> **NCT00233896** · PHASE3 · COMPLETED · sponsor: **Enteron Pharmaceuticals** · enrollment: 130 (—)

## Conditions studied

- Graft Vs Host Disease
- Gastrointestinal Graft-Versus-Host Disease

## Interventions

- **DRUG:** Oral beclomethasone dipropionate (drug)

## Key facts

- **NCT ID:** NCT00233896
- **Lead sponsor:** Enteron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 130 (—)
- **Last updated:** 2005-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233896, "Randomized Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal GVHD". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00233896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*